| Literature DB >> 10762754 |
G I Salti1, S Grewal, R R Mehta, T K Das Gupta, A W Boddie, A I Constantinou.
Abstract
The present study was undertaken to determine if (a) genistein induces topo II-mediated DNA damage in HT-29 colon cancer cells; and (b) if this damage is required to induce apoptosis. DNA damage was evaluated using the comet assay. Apoptosis was determined by the ethidium bromide/acridine orange staining technique. DNA breakage was noted within 1 h of treatment. Apoptosis was only induced with high concentrations (>/=60 microM) of genistein. Marked inhibition of HT-29 cell growth was evident at concentrations ranging from 60 to 150 microM. This was associated with a cell cycle arrest at G(2)/M. Similar findings were obtained in SW-620 and SW-1116 colon cancer cell lines. Aclarubicin, a topo II antagonist, reduced genistein-induced DNA breaks but did not reduce apoptosis. These data suggest that, in colon cancer cells, topo II serves as the enzymatic target of genistein. Furthermore, topo II-mediated DNA cleavage is not required for the induction of apoptosis.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10762754 DOI： 10.1016/s0959-8049(00)00017-4
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162